Ledger.Open graph →
SEC Form D · Amendment · filed February 24, 2017

Axcella Health Inc

Offering
—
Sold
$42.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

John B. Mendlein · CAMBRIDGE, MADirectorAndrew Smith · Philadelphia, PAExecMarika Tooze · Philadelphia, PAExec · DirectorChristopher R. Manning · NEW YORK, NYDirectorPeter B. Hutt · CAMBRIDGE, MADirectorRobert Connelly · CAMBRIDGE, MAExec · DirectorSean G. Mcgrath · VANCOUVER, British Columbia, CanadaDirectorGregory Behar · CAMBRIDGE, MADirectorDavid J. Stone · VANCOUVER, British Columbia, CanadaDirectorRichard Fonash · Philadelphia, PAExec · DirectorNoubar Afeyan · CAMBRIDGE, MADirectorStephen Hoge · CAMBRIDGE, MADirectorJeff B. Moore · CAMBRIDGE, MAExecGary B. Pisano · CAMBRIDGE, MADirectorSusan Mullin · Philadelphia, PADirectorJennifer A. Nichols · Philadelphia, PADirectorDavid Berry · CAMBRIDGE, MADirectorCharles Cooney · CAMBRIDGE, MADirectorCharles Ayres · NEW YORK, NYDirectorJeffrey L. Cotton · Philadelphia, PADirectorAlan R. Goodson · Philadelphia, PADirectorEugene D. James · NEW YORK, NYDirectorRobert J. Thatcher · Brooklyn Park, MNDirectorGlenn K. Mitchell · Grand Cayman, Cayman IslandsDirectorFrank S. Ioppolo · Lake Mary, FLDirectorChristopher Edwards · Philadelphia, PADirectorChris B. Viehbacher · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗